Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 during Unfavourable Peritoneal Tissue Remodelling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Rusan Catar and Guido Moll et al

Journal title: Frontiers in Immunology

Journal publisher: Frontiers media

Published year: 2021

DOI identifier: 10.3389/fimmu.2022.821681

ISSN: 1664-3224